Correlation Between C4 Therapeutics and Intel

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both C4 Therapeutics and Intel at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining C4 Therapeutics and Intel into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between C4 Therapeutics and Intel, you can compare the effects of market volatilities on C4 Therapeutics and Intel and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in C4 Therapeutics with a short position of Intel. Check out your portfolio center. Please also check ongoing floating volatility patterns of C4 Therapeutics and Intel.

Diversification Opportunities for C4 Therapeutics and Intel

0.18
  Correlation Coefficient

Average diversification

The 3 months correlation between CCCC and Intel is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding C4 Therapeutics and Intel in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intel and C4 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on C4 Therapeutics are associated (or correlated) with Intel. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intel has no effect on the direction of C4 Therapeutics i.e., C4 Therapeutics and Intel go up and down completely randomly.

Pair Corralation between C4 Therapeutics and Intel

Given the investment horizon of 90 days C4 Therapeutics is expected to generate 2.59 times more return on investment than Intel. However, C4 Therapeutics is 2.59 times more volatile than Intel. It trades about 0.15 of its potential returns per unit of risk. Intel is currently generating about 0.02 per unit of risk. If you would invest  138.00  in C4 Therapeutics on May 15, 2025 and sell it today you would earn a total of  94.00  from holding C4 Therapeutics or generate 68.12% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

C4 Therapeutics  vs.  Intel

 Performance 
       Timeline  
C4 Therapeutics 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in C4 Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak fundamental indicators, C4 Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.
Intel 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Intel are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound basic indicators, Intel is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

C4 Therapeutics and Intel Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with C4 Therapeutics and Intel

The main advantage of trading using opposite C4 Therapeutics and Intel positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if C4 Therapeutics position performs unexpectedly, Intel can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intel will offset losses from the drop in Intel's long position.
The idea behind C4 Therapeutics and Intel pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Transaction History
View history of all your transactions and understand their impact on performance